Skip to main content
Asian Pacific Journal of Cancer Prevention : APJCP logoLink to Asian Pacific Journal of Cancer Prevention : APJCP
. 2024;25(9):3143–3149. doi: 10.31557/APJCP.2024.25.9.3143

Snail Expression as a Prognostic Factor in Colorectal Adenocarcinoma

Gina Andyka Hutasoit 1,2, Upik Anderiani Miskad 1,3,*, Fardah Akil 4, Muhammad Husni Cangara 1,3, Haslindah Dahlan 1,3, Amalia Yamin 1,5, Mardiati Mardiati 3
PMCID: PMC11700324  PMID: 39342593

Abstract

Objective:

The aim of this study was to analyze the expression of Snail in the colorectal adenocarcinoma.

Methods:

This study used a cross-sectional design. Seventy four paraffin embedded block of Colorectal Adenocarcinoma were assessed using Snail rabbit polyclonal antibody and their expression were performed using Olympus CX-43 light microscope. The relationship between Snail expression with histopathological grading, tumor budding grading, lymphovascular invasion and metastases of colorectal adenocarcinoma ability were statistically analyzed by Mann Whitney tests and presented in tables using SPSS 27.

Result:

From 74 samples examined, in samples with low grade tumor budding (n=11), there were 9 samples (81.8%) with weak expression, while those with strong expression were 2 samples (18.2%). In samples with intermediate grade tumor budding (n=28), there were 17 samples (60.7%) with weak expression, while those with strong expression were 11 samples (39.3%). In samples with high grade tumor budding (n=35), there were 13 samples (37.1%) with weak expression, while those with strong expression were 22 samples (62.9%). In samples with lymphovascular invasion (n=14), there were 10 samples (71.4%) with strong expression, while those with weak expression were 4 samples (28.6%). In samples with metastases (n=23), there were 16 samples (69.6%) with strong expression, while those with weak expression were 7 samples (30.4%). There was a significant relationship between the expression of Snail with tumor budding grade (p=0.003), lymphovascular invasion and metastases (p=<0.001), but there was no significant relationship with histopathological grade (p=0.942).

Conclusion:

The Snail expression can be used as a prognostic factor in colorectal adenocarcinoma.

Key Words: Colorectal adenocarcinoma, Snail, histopathological, tumor budding

Introduction

Colorectal carcinoma is a malignant epithelial tumor of the colon and/or rectum. Adenocarcinoma is the most common, accounting for more than 90% of all colorectal carcinoma cases [1]. Colorectal carcinoma affects both men and women, and is one of the most common cancers in both developed and developing countries. Colorectal carcinoma is also one of the most common causes of cancer deaths worldwide. The incidence of colorectal carcinoma in Indonesia also receives special attention because new cases and death rates continue to increase every year. According to GLOBOCAN data in 2020, the incidence of new colorectal cancer in Indonesia was 33,427 cases or around 8.4% of the total 396,914 cancer cases.

Currently, early detection and prompt treatment have been developing well, but some cases of the advanced stage still can be found. Thus, colorectal carcinoma remains the main cause of cancer death [2]. Various prognostic factors have been studied in predicting the outcome of colorectal carcinoma patients, including the role of various clinicopathological factors. The histopathological parameters that are routinely assessed in the evaluation of histopathological preparations for colorectal cancer are the histopathological grade of the tumor, lymphovascular invasion (LVSI) status, degree of inflammation, margin status, nodal status, and Tumor Node and Metastasis (TNM) stage [3]. The histopathological grade assessment of colorectal carcinoma is based on gland formation, low grade and high grade [4]. Currently, specific morphological features are starting to be researched, namely the presence of tumor budding which is associated with tumor aggressiveness [5]. Tumor budding is defined as the presence of single tumor cells or small groups of up to four cells in the peritumoral stroma, whose tumor growth has been linked to Epithelial Mesenchymal Transition (EMT) [6].

Epithelial Mesenchymal Transition is a biological process that allows polarized cells to interact with the basement membrane and then to assume a mesenchymal phenotype characterized by increased migratory capacity, invasiveness, increased resistance to apoptosis and increased production of extracellular matrix (ECM) components [7]. During EMT, carcinoma cells become more motile and invasive by acquiring characteristics similar to embryonic mesenchymal cells. Therefore, carcinoma cell penetration of the stroma surrounding the initial neoplastic focus can be occured. The transcription factor which is a repressor of E-cadherin is Snail [8].

Snail proteins and their families are transcriptional repressor factors. Snail is a repressor transcription factor for the E-Cadherin protein which is a factor in the formation of EMT. The Snail family of proteins plays a key role in regulating the EMT process, acting as transcription factors to control the expression of genes whose products determine the EMT phenotype and ultimately the development of a neoplasm. Snail protein can be identified in the stage of carcinogenesis, invasion, and metastasis. Snail expression on tumor cells can characterize the degree of malignancy and serve as a prognostic marker of the disease [9].

Therefore, this study assessed whether Snail expression correlates with histopathological grading, tumor budding grading, lymphovascular invasion and metastases of colorectal adenocarcinoma, so that it can be one of the candidate prognostic biomarkers of colorectal adenocarcinoma.

Materials and Methods

From January 2020 to Juny 2023, we obtained 74 paraffin block samples from patients who had been diagnosed with colorectal adenocarcinoma at the Anatomical Pathology Laboratory Dr. Wahidin Sudirohusodo, Hasanuddin University, and Makassar Pathology Diagnostic Center for this study. Snail rabbit polyclonal antibody immunohistochemical staining was carried out on slides that had not been stained. The paraffin blocks were used to create slides, which were subsequently cut using a 3 µm thick microtome. A poly-L-lysinie slide was used to take the cut in the water bath, and it was later deparaffinized using Snail rabbit polyclonal antibody for immunohistochemical staining.

Using a 400x light microscope, the expression of Snail was examined on the nuclear or cytoplasm of tumor cells. Assessment performed by two pathologists who were blinded of clinical data and results. The intensity and proportion of stained tumor cells were used to score Snail expression in a semiquantitative manner, and the total immunostaining score (TIS) was used to determine the overall score. The Snail expression score is the total immunostaining score (0-9) obtained by multiplying the proportion score of the tumor area stained positively (0-3) with the Snail staining intensity score (0-3). The proportion score 0: None; 1: Stained <10%; 2: Stained 10-50%; 3: >50%. The intensity of Snail: uncolored: 0/negative; weak: +1; moderate: +2; strong: +3. Furthermore, Snail expression was declared strong if TIS ≥6 and weak if TIS <6 [10].

Statistical Program for Social Science (SPSS) 27 for Windows was used to process the data for this investigation. To evaluate the correlation between categorical variables, the Mann Whitney test was applied.

Results

Table 1 shows the distribution of the 74 samples of colorectal adenocarcinoma by age, gender, tumor location, histopathological grading, tumor budding grading, lymphovascular invasion, metastases and Snail expression (Figure 1).

Table 1.

Characteristics of the Sample

Characteristics n (%)
Strong 35 (47.3)
Age (yrs)
<50 20 (27.0)
≥50 54 (73.0)
mean ± SD= 54,89 ± 10,98
Gender
Male 39 (52.7)
Female 35 (47.3)
Tumor location
Proximal 31 (41.9)
Distal 31 (41.9)
Rectum 12 (16.2)
Histopathological grade
Low grade 64 (86.5)
High grade 10 (13.5)
Tumor budding
Low grade 11 (14.9)
Intermediate grade 28 (37.8)
High grade 35 (47.3)
LVSI
Positive 14 (18.9)
Negative 60 (81.1)
Metastases
Positive 23 (31.1)
Negative 51 (68.9)
Snail Expression
Weak 39 (52.7)

Figure 1.

Figure 1

Tumor Budding in Adenocarcinoma Colorectal. A, low grade; B, Intermediate grade; C, High grade (200x Magnification).

Based on Table 1, it can be seen that this study used a total of 74 samples, which the mean of age was 54.89 years old with a standard deviation of 10.98 years old. Samples with the age category <50 years were 20 samples (27,0%) and the age category >50 years were 54 samples (73,0%). There were 39 samples of male (52,7%) and 35 samples of female (47,3%). Based on the location of the tumor, the location of tumor in the proximal colon were 31 samples (41,9%), in the distal colon were 31 samples (41,9%), and in the rectum were 12 samples (16,2%). The low-grade colorectal adenocarcinoma group were consisted of 64 samples (86,5%) and 10 samples (13.5%) of the high-grade. Samples with low grade tumor budding were 11 samples (14,9%), intermediate grade tumor budding were 28 samples (37,8%) and high grade tumor budding were 35 samples (47,3%). Samples with positive lymphovascular invasion were 14 samples (18.9%) and 60 samples (81.1%) were negative. Samples with metastases were 23 samples (31.1%), while those without metastases were 51 samples (68.9%). Snail expression with strong expression were 35 samples (47.3%), while those with weak expression were 39 samples (52.7%). Snail immunohistochemical examination results were assessed using a semi-quantitative scoring system based on proportion and color intensity. Tumor cells nuclear or cytoplasms both displayed varying amounts and intensities of Snail expression. An example of Snail expression assessment for each color intensity is shown in Figure 2 below.

Figure 2.

Figure 2

Snail Expression in Colorectal Adenocarcinoma. A-B, Strong; C-D, Moderate; E-F, Weak; G-H, Negative (200x and 400x Magnification).

Table 2 shows that from 74 samples of colorectal adenocarcinoma, in high grade group there were 6 samples (11.3%) with strong expression and 4 samples with weak expression (19.0%). Meanwhile, in low grade group there were 47 samples (88.7%) had a strong expression and 17 samples (81.0%) had a weak expression. In samples with high grade tumor budding there were 22 samples (62.9%) with strong expression, while those with weak expression were 13 samples (37.1%). For samples with intermediate grade tumor budding there were 11 samples (39.3%) with strong expression, while those with weak expression were 17 samples (60.7%). And for samples with low grade tumor budding there were 2 samples (18.2%) with strong expression, while those with weak expression were 9 samples (81.8%). In samples with lymphovascular invasion there were 10 samples (71.4%) with strong expression, while those with weak expression were 4 samples (28.6%). For samples without lymphovascular invasion, there were 25 samples (41.7%) with strong expression and 35 samples (58.3%) with weak expresion. Regarding to the metastases, there were 16 samples with metastases and strong expression of Snail (69.6%), while 7 samples with weak expression (30.4%). For samples without metastases, there were 19 samples (37.3%) with strong expression and 32 samples (62.7%) with weak expression. Based on statistical analysis using Mann Whitney test, it shows that there were a significant relationship between Snail expression with tumor budding grading (p=0.003), lymphovascular invasion and metastases (p=<0.001), but there were no relationship between Snail expression with histopathological grading (p=0.942).

Table 2.

Relationship of Snail Expression with Histopathological and Tumor Budding Grade

Percent of Snail stained cells
Negative 23 16 (69,6) 2,87 ± 0,44
Characteristics No. of Patients Snail positive No. (%) P value* (Mean ± SE) P value
Age (yrs)
<50 20 10 (50) 0.983 5,10 ± 0,62 0,384***
≥50 54 25 (46,3) 4,44 ± 0,43
Gender
Male 39 18 (46,2) 1,000 4,64 ± 0,49 0,987***
Female 35 17 (48,6) 4,60 ± 0,53
Tumor location
Proximal 31 12 (38,7) 0.285 4,00 ± 0,51 0,371**
Distal 31 18 (58,1) 5,23 ± 0,55
Rectum 12 5 (41,7) 4,67 ± 0,36
Histopathological grade
Low 64 47 (73,4) 0.456 4,50 ± 1,02 0,942***
High 10 6 (60) 4,64 ± 0,38
Tumor budding grade
Low 11 2 (18,2) 0,020 1,09 ± 0,89 0,003**
Intermediate 28 11 (39,3) 1,43 ± 0,57
High 35 22 (62,9) 1,97 ± 0,46
LVSI
Positive 60 25 (41,7) 0.087 1,22 ± 0,41 < 0,001***
Negative 14 10 (71,4) 3,43 ± 0,62
Metastases
Positive 51 19 (37,3) 0,020 1,08 ± 0,46 < 0,001***

*, Chi-square test; **, Kruskal Wallis test; ***, Mann Whitney test

Discussion

One of the transcription factors that plays a role in epithelial to mesenchymal transition is Snail. Snail is a transcriptional repressor containing a highly conserved C-terminal region including four and five zinc fingers and is involved in protein binding to target gene promoters containing E-box sequences and an N-terminal region containing the evolutionary SNAG domain required for transcriptional repression and is capable of binds methyltransferases and histone deacetylases [9]. The Snail family includes Snail-1 (Snail), Snail-2 (Slug) and Snail-3 (Smuc), and has been shown to be over-expressed in a wide variety of human malignancies including oral, breast, hepatocellular, gastric, colon and skin carcinomas. Snail is typically localized in the nucleus. However, the subcellular localization and stability are sensitive to Ser/ Thr phosphorylation, when after being phosphorylated, Snail is translocated to the cytosol, where it is not active and is subsequently degraded [11]. In malignant tumor cells, Snail activates the TGF-β and Wnt pathways thus promoting tumor cell growth [12]. In some types of tumors, especially in colorectal cancer, excessive expression of Snail may associated with cancer progression and poorer prognosis [13].

In our study, there was no association between Snail expression and histopathological grade (Table 2). This finding is correlate with the report [14] which showed there was no relationship between Snail expression and various clinicopathological parameters including age, sex and histopathological grade in colorectal carcinoma. Apart from colorectal carcinoma, Snail expression was also found to be unrelated to histopathological grade in breast carcinoma and hepatocellular carcinoma [15, 16]. Due to the complex multistep molecular etiology of CRC, which includes many genetic and epigenetic changes, there are differences in Snail expression [13].

Epithelial-mesenchymal transition (EMT) is a biological process of polarized epithelial cells. The polarized cells are interacting with the basement membrane through their basal surface, undergoing several biochemical changes that allow them to assume the phenotype of mesenchymal cells, which include increased migratory capacity, invasive properties, increased resistance to apoptosis, and increased production of ECM components. EMT is characterized by degradation of the underlying basement membrane and the formation of mesenchymal cells that can migrate away from the epithelial layer from which they originate [17]. In tumorgenesis, EMT is an important process that gives tumor cells the ability to migrate out of the primary tumor and metastasize to distant sites. This is associated with a worse prognosis for cancer patients [18]. Furthermore, EMT can induce a cancer stem cell (CSC)-like phenotype in a number of tumor types [19]. After the tumor cells metastasize and reach their destination, the Mesenchymal- epithelial transition (MET) process plays a role. MET is the reverse process of epithelial-mesenchymal transition and has been shown to occur in normal development, inducing reprogramming, cancer metastasis and wound healing [17, 20]. Although relatively little is known about the role of MET in cancer when compared to the extensive research of EMT in tumor metastasis, MET is believed to participate in the formation and stabilization of distant metastases by allowing cancer cells to gain regain epithelial properties and integrate into distant organs. Between these two states, the cell is in an ‘intermediate state’, or what is called partial EMT.

Several transcription factors involved in controlling EMT. There are Snail, Twist, ZEB1/2, SIP1, and E12/ E47. Snail was first identified in Drosophila as having an important role in mesenchyme formation [21]. Snail is a transcription factor that contains a helix-loop-helix structure, and is reported to have the ability to suppress E-cadherin transcription, induce the expression of matrix metalloproteniase-2, thereby degrading the extracellular matrix [16]. Snail is a transcription factor that mediates EMT in a number of tumor types, including colorectal cancer (CRC). Snail plays a role in the pathogenesis of several malignant neoplasms, especially by promoting invasion and metastasis [19]. The Snail family, including Snail-1 (Snail), Snail-2 (Slug) and Snail-3 (Smuc), has been shown to be highly expressed in a variety of human malignancies including oral, breast, hepatocellular, gastric, colon and skin carcinomas [22]. Snail protein is expressed at high levels in the nucleus and cytoplasm of tumor cell adenomas and carcinomas. Snail is activated by several signaling pathways, including Wnt/β-catenin, TGF-β (transforming growth factor β), TNF-α (tumor necrosis factor α), RAS, ILK (integrin-linked kinase), NF- κB (nuclear factor κ-light chain enhancer of activated B cells), HIF (hypoxia-inducible factor), AKT activation and EGFR (epidermal growth factor receptor) signaling [11]. We also assessed the association of Snail expression with tumor budding grading, lymphovascular invasion and metastases (Table 2). This research data shows that Snail expression is higher in colorectal adenocarcinoma with high grade tumor budding compared with low grade and intermediate grade tumor budding. Statistically, it shows that there is a significant relationship between Snail expression and tumor budding grade. Tumor budding overall showed a loss of epithelial markers and an increase in mesenchymal markers compared to the primary tumor mass. Although the primary tumor mass consists primarily of pure epithelial cells, the tumor budding is very rich in pure mesenchymal cells and even hybrid epithelial- mesenchymal cells. EMT is controlled by a core regulatory circuit consisting of: two microRNAs, known as miR-34 and miR-200 respectively, and two transcription factors, referred to as SNAIL and ZEB1/2, which respectively stand for Zinc finger E-box-binding homeobox-1 or -2 [23]. In our study, statistically it shows that there is a significant relationship between Snail expression and low grade, intermediate grade and high grade tumor budding in colorectal adenocarcinoma. Other studies also reported that Snail expression was significantly correlated with the formation of tumor budding at the invasive front and the incidence of lymph node metastasis. Soluble TGF-β in the CRC microenvironment may participate in Snail-induced EMT and restoration of CSC-like properties, which may lead to metastasis in patients with stage II CRC [24].

Snail expression significantly correlated with vascular invasion in colorectal adenocarcinoma. Epithelial- mesenchymal transition is a fundamental process that regulates the nature of invasion. E-cadherin plays a major role in development, organogenesis and tissue formation, but also in tumor progression. Snail is a transcription factor described as a direct suppressor of E-cadherin during development and carcinogenesis. The expression of E-cadherin and Snail in colorectal adenocarcinoma reported that Snail showed statistically significant aspects associated with vascular invasion. The results obtained demonstrate the implication of Snail and E-cadherin in EMT of colorectal adenocarcinoma, which is a useful aspect in the evaluation of adenocarcinoma patients for specific therapeutic targets. Snail was overexpressed in the group with positive lymph nodes, whereas Twist was overexpressed in patients with other metastases. Expression of Snail and Twist correlated with reduced membrane expression of E-cadherin [25]. The study concluded that Snail overexpression was significantly correlated with lymph node metastasis in colorectal adenocarcinoma. Snail expression is a common sign of poor prognosis in metastatic cancer, and tumors with increased Snail expression are very difficult to treat with current therapeutic treatments [19]. The importance of Snail as a prognostic indicator, its involvement in the regulation of EMT and metastasis, and its role in drug resistance and immunity suggest that Snail is an attractive target for tumor growth inhibition and a target for sensitization to cytotoxic drugs [26].

The limitation of this study is that it only uses one type of prognostic marker with only one protein detection modality via immunohistochemistry, so it is still less accurate in analyzing the complexity of the relationship between Snail and various other molecules involved in regulating its expression, as well as its relationship to colorectal adenocarcinoma tumor budding, invasion and metastasis.

In conclusion, there is a significant relationship between Snail expression with tumor budding grading, lymphovascular invasion and metastases in colorectal adenocarcinoma. Snail expression in the high grade tumor budding group was higher than in the intermediate and low grade tumor budding groups. Snail expression in the lymphovascular invasion group are higher than in without lymphovascular invasion group. While, Snail expression in the metastatic group are higher than in the non- metastatic group. There is no relationship between Snail expression and histopathological grade. Snail expression affects tumor budding grading, invasion and metastasis of colorectal carcinoma but does not play a role in histopathological grading. So, the Snail expression can be used as a prognostic factor in colorectal adenocarcinoma.

Acknowledgements

The Anatomical Pathology Laboratory at Hasanuddin University Hospital contributed to the feasibility of this study in part.

Funding Statement

This research was supported by Faculty of Medicine, Hasanuddin University, in collaborative research grants program 2023 (7096/UN4.6/PT.01.05/2023).

Study Approval

This work was permitted by the research committee of the Faculty of Medicine, Hasanuddin University.

Ethical approval

The Faculty of Medicine’s Ethics Committee waived informed consent for this study (Protocol #UH23070526 – Registry No. 621/UN4.6.4.5.31/PP36/2023).

Availability of Data

On reasonable request, the associated author will release the datasets used in this work.

Conflict of Interest

All authors state that they have no conflicting interests in this research.

Author Contribution Statement

All authors contributed equally in this study and approved the final manuscript.

References

  • 1.Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol. 2012;3(3):153–73. doi: 10.3978/j.issn.2078-6891.2012.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Li CJ, Zhang X, Fan GW. Updates in colorectal cancer stem cell research. J Cancer Res Ther. 2014;10 Suppl:233–9. doi: 10.4103/0973-1482.151449. [DOI] [PubMed] [Google Scholar]
  • 3.Langrand-Escure J, Diao P, Garcia MA, Wang G, Guy JB, Espenel S, et al. Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: A mono-institutional survey. Sci Rep. 2018;8(1):10708 . doi: 10.1038/s41598-018-29040-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Miskad UA, Hamzah N, Cangara MH, Nelwan BJ, Masadah R, Wahid S. Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in colorectal adenocarcinoma. Minerva Med. 2020;111(4):337–43. doi: 10.23736/S0026-4806.20.06401-0. [DOI] [PubMed] [Google Scholar]
  • 5.Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, et al. Recommendations for reporting tumor budding in colorectal cancer based on the international tumor budding consensus conference (itbcc) 2016. Mod Pathol. 2017;30(9):1299–311. doi: 10.1038/modpathol.2017.46. [DOI] [PubMed] [Google Scholar]
  • 6.Hacking S, Angert M, Jin C, Kline M, Gupta N, Cho M, et al. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases. Ann Diagn Pathol. 2019;43:151420. doi: 10.1016/j.anndiagpath.2019.151420. [DOI] [PubMed] [Google Scholar]
  • 7.Zhou Y, Xia L, Wang H, Oyang L, Su M, Liu Q, et al. Cancer stem cells in progression of colorectal cancer. Oncotarget. 2018;9(70):33403–15. doi: 10.18632/oncotarget.23607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, et al. E-cadherin/β-catenin complex and the epithelial barrier. J Biomed Biotechnol. 2011;2011:567305. doi: 10.1155/2011/567305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Yastrebova MA, Khamidullina AI, Tatarskiy VV, Scherbakov AM. Snail-family proteins: Role in carcinogenesis and prospects for antitumor therapy. Acta Naturae. 2021;13(1):76–90. doi: 10.32607/actanaturae.11062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Luo WR, Li SY, Cai LM, Yao KT. High expression of nuclear snail, but not cytoplasmic staining, predicts poor survival in nasopharyngeal carcinoma. Ann Surg Oncol. 2012;19(9):2971–9. doi: 10.1245/s10434-012-2347-x. [DOI] [PubMed] [Google Scholar]
  • 11.Bezdekova M, Brychtova S, Sedlakova E, Langova K, Brychta T, Belej K. Analysis of snail-1, e-cadherin and claudin-1 expression in colorectal adenomas and carcinomas. Int J Mol Sci. 2012;13(2):1632–43. doi: 10.3390/ijms13021632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lugli A, Zlobec I, Berger MD, Kirsch R, Nagtegaal ID. Tumour budding in solid cancers. Nat Rev Clin Oncol. 2021;18(2):101–15. doi: 10.1038/s41571-020-0422-y. [DOI] [PubMed] [Google Scholar]
  • 13.Wang W, Jin J, Zhou Z, Wang Y, Min K, Zuo X, et al. Snail inhibits metastasis via regulation of e-cadherin and is associated with prognosis in colorectal cancer. Oncol Lett. 2023;25(6):271. doi: 10.3892/ol.2023.13857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kroepil F, Fluegen G, Vallböhmer D, Baldus SE, Dizdar L, Raffel AM, et al. Snail1 expression in colorectal cancer and its correlation with clinical and pathological parameters. BMC Cancer. 2013;13:145 . doi: 10.1186/1471-2407-13-145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, et al. Correlation of snail expression with histological grade and lymph node status in breast carcinomas. Oncogene. 2002;21(20):3241–6. doi: 10.1038/sj.onc.1205416. [DOI] [PubMed] [Google Scholar]
  • 16.Woo HY, Min AL, Choi JY, Bae SH, Yoon SK, Jung CK. Clinicopathologic significance of the expression of snail in hepatocellular carcinoma. Korean J Hepatol. 2011;17(1):12–8. doi: 10.3350/kjhep.2011.17.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kalluri R. Emt: When epithelial cells decide to become mesenchymal-like cells. J Clin Invest. 2009;119(6):1417–9. doi: 10.1172/JCI39675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kreizenbeck GM, Berger AJ, Subtil A, Rimm DL, Gould Rothberg BE. Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2008;17(4):949–58. doi: 10.1158/1055-9965.EPI-07-2729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fan F, Samuel S, Evans KW, Lu J, Xia L, Zhou Y, et al. Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Med. 2012;1(1):5–16. doi: 10.1002/cam4.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Pei D, Shu X, Gassama-Diagne A, Thiery JP. Mesenchymal- epithelial transition in development and reprogramming. Nat Cell Biol. 2019;21(1):44–53. doi: 10.1038/s41556-018-0195-z. [DOI] [PubMed] [Google Scholar]
  • 21.Chen WJ, Wang H, Tang Y, Liu CL, Li HL, Li WT. Multidrug resistance in breast cancer cells during epithelial- mesenchymal transition is modulated by breast cancer resistant protein. Chin J Cancer. 2010;29(2):151–7. doi: 10.5732/cjc.009.10447. [DOI] [PubMed] [Google Scholar]
  • 22.Poser I, Domínguez D, de Herreros AG, Varnai A, Buettner R, Bosserhoff AK. Loss of e-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor snail. J Biol Chem. 2001;276(27):24661–6. doi: 10.1074/jbc.M011224200. [DOI] [PubMed] [Google Scholar]
  • 23.Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. Tumor budding: The name is emt Partial emt. J Clin Med. 2016;5:5. doi: 10.3390/jcm5050051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yusra A, Semba S, Yokozaki H. Biological significance of tumor budding at the invasive front of human colorectal carcinoma cells. Int J Oncol. 2012;41(1):201–10. doi: 10.3892/ijo.2012.1459. [DOI] [PubMed] [Google Scholar]
  • 25.Al Khatib AM, Stepan AE, Margaritescu C, Simionescu C, Ciurea RN. E-cadherin and snail immunoexpression in colorectal adenocarcinomas. Curr Health Sci J. 2019;45(2):204–9. doi: 10.12865/CHSJ.45.02.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kaufhold S, Bonavida B. Central role of snail1 in the regulation of emt and resistance in cancer: A target for therapeutic intervention. J Exp Clin Cancer Res. 2014;33(1):62 . doi: 10.1186/s13046-014-0062-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

On reasonable request, the associated author will release the datasets used in this work.


Articles from Asian Pacific Journal of Cancer Prevention : APJCP are provided here courtesy of West Asia Organization for Cancer Prevention

RESOURCES